Published in J Infect Dis on February 01, 1985
Pathophysiology of Campylobacter enteritis. Microbiol Rev (1986) 4.94
Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States. J Clin Microbiol (1989) 2.52
Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. J Clin Invest (1988) 2.38
Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun (2002) 2.28
Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect Immun (2000) 1.95
Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus. Infect Immun (1985) 1.88
Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev (2008) 1.76
Pathogenesis of Campylobacter fetus infections. Role of surface array proteins in virulence in a mouse model. J Clin Invest (1990) 1.58
Lipopolysaccharide structures of Campylobacter fetus are related to heat-stable serogroups. Infect Immun (1986) 1.52
Extraintestinal Campylobacter infections. West J Med (1986) 1.50
Shift in S-layer protein expression responsible for antigenic variation in Campylobacter fetus. J Bacteriol (1993) 1.46
The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect Immun (2000) 1.41
Reattachment of surface array proteins to Campylobacter fetus cells. J Bacteriol (1992) 1.40
Detection of pathogenic Campylobacter species in blood culture systems. J Clin Microbiol (1986) 1.36
Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation. Infect Immun (1988) 1.24
Prevalence, antigenic specificity, and bactericidal activity of poultry anti-Campylobacter maternal antibodies. Appl Environ Microbiol (2001) 1.22
Clinical aspects of Campylobacter jejuni infections in adults. West J Med (1994) 1.21
Nested DNA inversion as a paradigm of programmed gene rearrangement. Proc Natl Acad Sci U S A (1997) 1.17
Bacteraemia caused by Campylobacter spp. J Clin Pathol (1994) 1.17
Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis. J Bacteriol (2010) 1.16
Comparative genome analysis of Campylobacter fetus subspecies revealed horizontally acquired genetic elements important for virulence and niche specificity. PLoS One (2014) 1.14
Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob Agents Chemother (1993) 1.10
Campylobacter infections: the emerging national pattern. Am J Public Health (1987) 1.09
Surface array proteins of Campylobacter fetus block lectin-mediated binding to type A lipopolysaccharide. Infect Immun (1990) 1.07
Campylobacter fetus surface layer proteins are transported by a type I secretion system. J Bacteriol (1998) 1.07
Two-dimensional gel electrophoresis and immunoblotting of Campylobacter outer membrane proteins. Infect Immun (1987) 1.05
Human immune response to Campylobacter jejuni proteins expressed in vivo. Infect Immun (1992) 1.03
Comparison of different vaccines and induced immune response against Campylobacter jejuni colonization in the infant mouse. Epidemiol Infect (1989) 1.02
Campylobacter jejuni strains from patients with Guillain-Barré syndrome. Emerg Infect Dis (1998) 1.02
Lipopolysaccharide structures in Enterobacteriaceae, Pseudomonas aeruginosa, and Vibrio cholerae are immunologically related to Campylobacter spp. Infect Immun (1986) 1.01
Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence (2011) 0.99
Plasma cytokine response in mice with bacterial infection. Mediators Inflamm (2000) 0.97
Campylobacter jejuni cocultured with epithelial cells reduces surface capsular polysaccharide expression. Infect Immun (2009) 0.95
Development of experimental genetic tools for Campylobacter fetus. Appl Environ Microbiol (2007) 0.94
Campylobacter fetus sap inversion occurs in the absence of RecA function. Infect Immun (2000) 0.93
In vitro evaluation of the role of antibodies against Helicobacter pylori in inhibiting adherence of the organism to gastric cells. Gut (1997) 0.91
Biological roles of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. PLoS One (2014) 0.90
Campylobacter surface-layers (S-layers) and immune evasion. Ann Periodontol (2002) 0.90
Immune response of athymic and euthymic germfree mice to Campylobacter spp. Infect Immun (1986) 0.90
So close and yet so far - Molecular Microbiology of Campylobacter fetus subspecies. Eur J Microbiol Immunol (Bp) (2012) 0.88
Spondylodiscitis and an aortic aneurysm due to Campylobacter coli. Ann Clin Microbiol Antimicrob (2010) 0.84
Clonal distribution and virulence of Campylobacter jejuni isolates in blood. Emerg Infect Dis (2013) 0.83
Characterization of a Campylobacter jejuni VirK protein homolog as a novel virulence determinant. Infect Immun (2009) 0.82
Indwelling device-related bacteremia caused by serum-susceptible Campylobacter coli. J Clin Microbiol (1997) 0.82
Enteroinvasive Escherichia coli: a cause of bacteremia in patients with AIDS. J Clin Microbiol (1991) 0.81
Lipooligosaccharide locus class of Campylobacter jejuni: sialylation is not needed for invasive infection. Clin Microbiol Infect (2013) 0.81
Virulence of Campylobacter jejuni for chicken embryos is associated with decreased bloodstream clearance and resistance to phagocytosis. Infect Immun (1991) 0.81
Identification of immunogenic and virulence-associated Campylobacter jejuni proteins. Clin Vaccine Immunol (2011) 0.80
Campylobacter prosthetic joint infection. J Clin Microbiol (2014) 0.79
Virulence characteristics of five new Campylobacter jejuni chicken isolates. Gut Pathog (2013) 0.77
Cj1411c encodes for a cytochrome P450 involved in Campylobacter jejuni 81-176 pathogenicity. PLoS One (2013) 0.77
A Phase-Variable Surface Layer from the Gut Symbiont Bacteroides thetaiotaomicron. MBio (2015) 0.75
Phase variable changes in the position of O-methyl phosphoramidate modifications on the polysaccharide capsule of Campylobacter jejuni modulate serum resistance. J Bacteriol (2017) 0.75
Answer to November 2017 Photo Quiz. J Clin Microbiol (2017) 0.75
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Campylobacter enteritis. N Engl J Med (1981) 7.98
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Sociodemographic characteristics of cigarette smoking initiation in the United States. Implications for smoking prevention policy. JAMA (1990) 2.97
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. Clin Exp Immunol (1969) 2.81
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Lipids of Thermoplasma acidophilum. J Bacteriol (1972) 2.69
DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest (1973) 2.66
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis (2000) 2.42
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. J Clin Invest (1988) 2.38
Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature (1966) 2.37
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Campylobacter enteritis associated with unpasteurized milk. Am J Med (1979) 2.19
Cryoimmunoglobulins. Semin Hematol (1973) 2.18
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17
An outbreak of waterborne giardiasis associated with heavy water runoff due to warm weather and volcanic ashfall. Am J Public Health (1983) 2.16
Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis (1993) 2.15
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Cellular fatty acid composition of Campylobacter fetus. J Clin Microbiol (1980) 2.14
Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg (1971) 2.14
Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun (1998) 2.14
Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect (1999) 2.10
Phospholipids and glycolipids of sterol-requiring Mycoplasma. J Bacteriol (1967) 2.08
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis (1984) 2.04
From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis (1981) 2.04
Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis (1986) 2.04
Allelic Variation within Helicobacter pylori babA and babB. Infect Immun (2001) 2.02
Outbreaks of Campylobacter enteritis in two extended families: evidence for person-to-person transmission. J Pediatr (1981) 2.01
Characteristics of Helicobacter pylori variants selected for urease deficiency. Infect Immun (1992) 2.01
The lipid composition of Mycoplasma laidlawii strain B. Biochem J (1968) 2.00
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Campylobacter jejuni outer membrane proteins are antigenic for humans. Infect Immun (1984) 1.99
Identification of type II restriction and modification systems in Helicobacter pylori reveals their substantial diversity among strains. Proc Natl Acad Sci U S A (2000) 1.98
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun (1993) 1.97
Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates. Gastroenterology (1999) 1.96
Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med (1996) 1.96
PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J Clin Microbiol (1994) 1.96
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
Lipids of a sterol-nonrequiring Mycoplasma. J Bacteriol (1970) 1.92
Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus. Infect Immun (1985) 1.88
Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status. Infect Immun (1996) 1.88